Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Mayo Clinic
Ohio State University Comprehensive Cancer Center
City of Hope Medical Center
M.D. Anderson Cancer Center
City of Hope Medical Center
Emory University
National Cancer Institute (NCI)
City of Hope Medical Center
M.D. Anderson Cancer Center
Mayo Clinic
National Cancer Institute (NCI)
Emory University
City of Hope Medical Center
M.D. Anderson Cancer Center
Thomas Jefferson University
University of Utah
M.D. Anderson Cancer Center
Mayo Clinic
City of Hope Medical Center
Osel, Inc.
Ohio State University Comprehensive Cancer Center
Emory University
OHSU Knight Cancer Institute
M.D. Anderson Cancer Center
Stanford University
Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI)
Innovent Biologics (Suzhou) Co. Ltd.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI)
Northwestern University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)